[ad_1]
News of emerging antonviral vaccines is constantly pouring in, but we hardly hear of a new drug against the disease “Covid 19”, while experts warn against focusing on vaccination and neglecting drugs that, in turn, contribute to alleviating the disease. pain of patients. and save their lives.
According to the American newspaper “New York Times”, thousands die every day in the United States as a result of the disease, while the vaccination process requires additional months to achieve herd immunity or at least be addressed.
The chief consultant for infectious diseases in the United States, Anthony Fauci, cautions that achieving herd immunity requires that approximately 85 percent of the population be vaccinated against the infection.
The source claimed that doctors are currently faced with limited drugs when treating people with the “Covid 19” disease that appeared in China late last year and then turned into a global pandemic.
Currently, there are Corona medications prepared on tiptoe, such as “remdesivir”, monoclonal antibodies and the steroid “dexamethasone”.
These properties have helped improve the condition of many since the increase in coronavirus cases in the United States last spring.
However, these drugs are provided only to limited groups of patients, according to the severity of the symptoms that appear in them, which means that the world still urgently needs anti-“Covid 19” drugs.
If the development of drugs against “Covid 19” has stalled, it is mainly due to the focus of the US government on the vaccine that achieves prevention, while efforts to find drugs have been neglected.
The United States spent nearly $ 18.5 billion on vaccine development, helping launch more than one corona virus vaccine, in a period described as standard, and it didn’t end in 2020 unless it was ready for emergency use.
In contrast, only $ 8.2 billion was spent on projects to develop drugs to treat “Covid 19,” and support was given only to limited projects, such as the monoclonal antibody treatment project.
Due to this disparity in support, the government missed the opportunity to develop drugs that would have saved many lives from the disease “Covid 19”, despite the existence of ideas that were described as promising.
Some researchers were unable to obtain funding to advance their projects or did not find volunteers to participate in the required studies.
At the beginning of the crisis, some researchers tried to take advantage of the drugs available in the market to treat “Covid 19”, but this bet did not pay much profit.
The French doctor and researcher promoted the drug “hydroxychloroquine” for malaria, and it was presented in many countries, but the results do not show proven efficacy, according to “The New York Times.”
According to data released by the University of Pennsylvania, there are currently 179 clinical trials on drugs for Corona, involving a sample of 169,370 people.
While some health experts are betting that Democratic President Joe Biden’s administration will advance projects and experiments to develop “Covid 19” drugs, researchers say these efforts were long overdue, because the bad is in the present and these medications may not ready during the current wave.
That is why the director of the US National Institutes of Health, Francis Collins, ruled out that any drug will be offered against Corona during the current year, “but in the event that there is Covid 24 or Covid 30, we want to be prepared “. “
alreadyLoaded_facebookConnect = false;
$(window).load(function () {
//$(window).bind('mousemove' , function(){ // $(window).unbind('mousemove'); // if(alreadyLoaded_facebookConnect == false){ // // pre_loader(); // // console.log("test"); // } //});
if ($(window).scrollTop() != 0 && alreadyLoaded_facebookConnect == false) {
alreadyLoaded_facebookConnect = true; (function (d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.async = true; js._https = true; js.src = "https://connect.facebook.net/en_US/all.js#xfbml=1&appId=148379388602322"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk')); // pre_loader(); // $(window).unbind('mousemove'); // console.log(" loaded"); //setTimeout(function(){ // $('#boxTwitter').html("Tweets by @tayyar_org"); //}, 3000);}}); //$(window).bind('scroll '); $ (window) .scroll (function () {if (alreadyLoaded_facebookConnect == false) {alreadyLoaded_facebookConnect = true ; // $ (window) .unbind ('scroll'); // console.log ("scroll loaded"); (function (d, s, id) {var js, fjs = d.getElementsByTagName (s)[0]; if (d.getElementById (id)) return; js = d.createElement (s); js.id = id; js.async = true; js._https = true; js.src = "https://connect.facebook.net/en_US/all.js#xfbml=1&appId=148379388602322"; fjs.parentNode.insertBefore (js, fjs); } (document, 'script', 'facebook-jssdk')); // pre_loader (); // $ (window) .unbind ('mousemove'); // setTimeout (function () {// $ ('# boxTwitter'). html ("Tweets from @tayyar_org"); //}, 3000); var scriptTag = document.createElement (" script "); scriptTag.type =" text / javascript "scriptTag.src =" https://news.google.com/scripts/social. js "; scriptTag.async = true; document.getElementsByTagName (" head ")[0].appendChild (scriptTag); (function () {$ .getScript ("https://news.google.com/scripts/social.js", function () {});}); }}); //$(window).load(function () {// setTimeout (function () {// // add the returned content to a newly created script tag // var se = document.createElement ('script'); / / se.type = "text / javascript"; // //se.async = true; // se.text = "setTimeout (function () {pre_loader ();}, 5000);"; // document. getElementsByTagName ('body')[0].appendChild (se); //}, 5000); //});
[ad_2]